- Founded
- 2019
- Business Model
- B2B
- Website
- bioptamers.com
- Total Funding
- $79K
- Last Round
- $79K Pre-SeedMar 2019
- Rounds
- 1
About
Personalized precision therapies
Summary
Bioptamers is a Biotech company, founded in 2019. It has raised $79K in total across 1 round, most recently a $79K Pre-Seed round in Mar 2019. Investors include SOSV.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2019
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company